Alamar Biosciences (ALMR) saw its stock price soar by 5.00% during intraday trading on Monday, reflecting strong investor interest in the newly listed company.
The surge follows the company's successful initial public offering on the NASDAQ Stock Exchange. Alamar Biosciences, a global leader in precision proteomics, issued shares at $17 each and opened trading at $22.6 per share, achieving a market capitalization of approximately $1.5 billion.
The company's proprietary NULISA™ technology and ARGO™ HT automated system have positioned it as a commercial-stage innovator in protein detection and analysis, serving over 300 customers across 25 countries. This successful market debut has generated positive momentum for the stock.
Comments